This work provides a new theoretical basis for clarifying the mechanism of NPC progression, and implies that ANRIL, miR-7-5p and TCF4 are potential diagnostic biomarkers and therapy targets. Here, CDKN2B-AS1 is linked to nasopharyngeal carcinoma.